Table 1 Proportion of patients receiving androgen deprivation therapy for inappropriate indications by year, stratified by urologist characteristics

Total

2214

100

44.2

44.3

46.6

44.7

36.2

33.4

31.1

Age (years):

<45

694

31.3

40.9

45.4

48.2

40.4

33.5

30.2

29.6

45 - 54

630

28.5

44.2

44.1

44.4

46.0

37.8

32.4

30.2

55 - 64

672

30.4

45.2

42.4

46.1

45.7

35.4

35.0

32.5

≥65

218

9.8

48.7

49.2

55.1

45.6

38.9

41.7

35.5

Sex:

Female

55

2.5

38.5

44.4

26.9

31.8

33.3

34.4

34.5

Male

2159

97.5

44.3

44.3

46.7

44.8

36.2

33.4

31.1

Years in practice:

<15

864

40.1

39.7

43.2

46.1

41.7

33.5

30.8

28.4

15 - 24

548

25.4

43.5

42.6

44.0

46.3

39.9

32.9

33.2

25 - 34

488

22.6

47.6

44.5

47.9

44.4

33.5

35.4

31.3

≥35

255

11.8

48.1

47.1

53.0

46.4

40.7

40.7

34.0

Board certification:

Yes

1725

77.9

44.6

44.1

46.0

44.2

36.1

33.5

30.9

No

489

22.1

42.7

44.9

48.8

46.4

36.8

33.0

31.9

Academic affiliation:

Major or Minor

1338

66.2

41.5

43.2

44.7

41.9

33.3

31.9

28.9

None

684

33.8

47.6

46.0

49.0

48.2

40.1

35.5

33.6

Patient panel size (no. of patients):

<14

685

30.9

37.7

44.7

42.1

46.1

34.7

35.6

29.2

14 - 44

603

27.2

39.8

40.6

47.3

43.1

36.7

32.0

30.1

45 - 74

452

20.4

47.2

48.2

47.2

44.9

37.8

33.4

36.0

≥75

474

21.4

47.6

43.7

49.3

44.6

35.6

32.9

29.0